What is Ligand Pharmaceuticals's change in AR?

Ligand Pharmaceuticals (LGND) reported change in AR of -$6.41M in Q1 2026.

How has Ligand Pharmaceuticals's change in AR changed year-over-year?

Ligand Pharmaceuticals's change in AR decreased by 1212.7% year-over-year, from $576K to -$6.41M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Ligand Pharmaceuticals LGND Change in AR

Change in AR at other companies

RevvityRVTY

-$61.55M-239%

BridgeBio PharmaBBIO

$65.78M-40.5%

Kiniksa Pharmaceuticals International, plcKNSA

$7.63M+560%

Ultragenyx PharmaceuticalRARE

-$19M-90.0%

ALN

Alnylam PharmaceuticalsALNY

$110.42M+1,385%

AbbVieABBV

-$87M-106%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.6B+96.7%

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's change in AR?: Ligand Pharmaceuticals (LGND) reported change in AR of -$6.41M in Q1 2026.
How has Ligand Pharmaceuticals's change in AR changed year-over-year?: Ligand Pharmaceuticals's change in AR decreased by 1212.7% year-over-year, from $576K to -$6.41M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.